Home
|
Contact
|
Imprint
|
Sitemap
|
Privacy notice
Toggle navigation
Home
About AiCuris
Company Profile
Management Team
Holger Zimmermann
Holger Schmoll
Alexander Birkmann
Helmut Buschmann
Manickam Rangaraju
Silvia Riffel-Friedrich
Scientific Advisory Board
Helga Rübsamen-Schaeff
Mark Wilcox
Per Ljungman
Memberships
Research & Development
Strategy
R&D Pipeline
Projects Overview
HCMV - Letermovir
HSV - Pritelivir (AIC316)
HBV - AIC649
HBV - Research
Adenovirus - Research
Bacteriology - Research
Pritelivir Early Access
Research Tools & Services
Partnering & Licensing
AiCuris & Partnering
Partnering Opportunities
Pritelivir (AIC316)
AIC649
In-Licensing & Collaborations
News & Media
Press releases
2020
2019
2018
2017 and before
Services for Press
Deutscher Zukunftspreis - 2018 Award Winners
EFPIA Disclosure Code
Career
Join AiCuris
Employee Benefits
Job Opportunities
Privacy Notice for applicants
Contact
Directions
Strategy
R&D Pipeline
Projects Overview
HCMV - Letermovir
HSV - Pritelivir (AIC316)
HBV - AIC649
HBV - Research
Adenovirus - Research
Bacteriology - Research
Pritelivir Early Access
Research Tools & Services
Prevymis
TM
Letermovir (AIC246)
Pritelivir (AIC316)
Herpes-simplex Virus (HSV)
AIC649
Hepatitis B
Adenovirus
- Research
Bacteriology
- Research
Site is still under construction:
HBV - Research
×
Close
